Perruzzi Carole A, de Fougerolles Antonin R, Koteliansky Victor E, Whelan Mary C, Westlin William F, Senger Donald R
Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
J Invest Dermatol. 2003 Jun;120(6):1100-9. doi: 10.1046/j.1523-1747.2003.12236.x.
Angiogenesis requires endothelial cell survival and proliferation, which depend upon cytokine stimulation together with integrin-mediated cell adhesion to extracellular matrix; however, the question of which specific integrins are the best targets for suppressing neovascularization is controversial and unresolved. Therefore, we designed experiments to compare contributions of individual integrins from both the alphav and beta1 integrin subfamilies. With immobilized antibodies, we determined that adhesion through integrins alpha1beta1, alpha2beta1, alphavbeta3, and alphavbeta5 each individually supported dermal microvascular endothelial cell survival. Also, substratum coated with collagen I (which binds alpha1beta1 and alpha2beta1) and vitronectin (which binds alphavbeta3 and alphavbeta5) each supported survival. Importantly, substratum coated with combinations of collagen I and vitronectin were most effective at promoting survival, and survival on three-dimensional collagen I gels was strongly enhanced by vitronectin. Vascular endothelial growth factor activation of the p44/p42 mitogen-activated protein kinase pathway, which is required for angiogenesis, was supported by adhesion through either alpha1beta1, alpha2beta1, alphavbeta3, or alphavbeta5, and pharmacologic inhibition of this pathway blocked proliferation and suppressed survival. Therefore, these studies establish that the alpha1beta1, alpha2beta1, alphavbeta3, and alphavbeta5 integrins each support dermal microvascular endothelial cell viability, and that each collaborate with vascular endothelial growth factor to support robust activation of the mitogen-activated protein kinase pathway which mediates both proliferation and survival. Moreover, survival is supported most significantly by extracellular matrices, which engage all of these integrins in combination. Consistent with important complementary and overlapping functions, combined antagonism of these integrins provided superior inhibition of angiogenesis in skin, indicating that multiplicity of integrin involvement should be considered in designing strategies for controlling neovascularization.
血管生成需要内皮细胞的存活和增殖,这依赖于细胞因子刺激以及整合素介导的细胞与细胞外基质的黏附;然而,关于哪些特定整合素是抑制新血管形成的最佳靶点这一问题存在争议且尚未解决。因此,我们设计了实验来比较αv和β1整合素亚家族中各个整合素的作用。使用固定化抗体,我们确定通过整合素α1β1、α2β1、αvβ3和αvβ5的黏附各自单独支持真皮微血管内皮细胞的存活。此外,包被有I型胶原(其结合α1β1和α2β1)和玻连蛋白(其结合αvβ3和αvβ5)的基质各自支持细胞存活。重要的是,包被有I型胶原和玻连蛋白组合的基质在促进存活方面最有效,并且在三维I型胶原凝胶上的存活因玻连蛋白而显著增强。血管内皮生长因子对血管生成所需的p44/p42丝裂原活化蛋白激酶途径的激活,通过α1β1、α2β1、αvβ3或αvβ5的黏附来支持,并且该途径的药理学抑制阻断了增殖并抑制了存活。因此,这些研究表明α1β1、α2β1、αvβ3和αvβ5整合素各自支持真皮微血管内皮细胞的活力,并且它们各自与血管内皮生长因子协同作用以支持介导增殖和存活的丝裂原活化蛋白激酶途径的强烈激活。此外,可以结合所有这些整合素的细胞外基质对存活的支持最为显著。与重要的互补和重叠功能一致,这些整合素的联合拮抗在皮肤中对血管生成提供了更好的抑制作用,表明在设计控制新血管形成的策略时应考虑整合素参与的多样性。